260 related articles for article (PubMed ID: 1322136)
1. Vasoactive intestinal peptide receptors in rat liver after partial hepatectomy.
Guijarro LG; Couvineau A; Rodriguez-Pena MS; Juarranz MG; Rodriguez-Henche N; Arilla E; Laburthe M; Prieto JC
Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):515-20. PubMed ID: 1322136
[TBL] [Abstract][Full Text] [Related]
2. Characterization of adenylyl cyclase stimulated by VIP in rat and mouse peritoneal macrophage membranes.
Pozo D; Segura JJ; Carrero I; Guijarro LG; Prieto JC; Calvo JR
Biochim Biophys Acta; 1996 Jul; 1312(3):249-54. PubMed ID: 8703995
[TBL] [Abstract][Full Text] [Related]
3. Analysis of vasoactive intestinal peptide receptors and the G protein regulation of adenylyl cyclase in seminal vesicle membranes from streptozotocin-diabetic rats.
Rodriguez-Pena MS; Guijarro LG; Juarranz MG; Rodriguez-Henche N; Bajo AM; Aguado F; Prieto JC
Cell Signal; 1994 Feb; 6(2):147-56. PubMed ID: 8086277
[TBL] [Abstract][Full Text] [Related]
4. Multiple defects occur in the guanine nucleotide regulatory protein system in liver plasma membranes of obese (fa/fa) but not lean (Fa/Fa) Zucker rats: loss of functional Gi and abnormal Gs function.
Houslay MD; Gawler DJ; Milligan G; Wilson A
Cell Signal; 1989; 1(1):9-22. PubMed ID: 2561940
[TBL] [Abstract][Full Text] [Related]
5. Functional and immunological evidence for stable association of solubilized vasoactive-intestinal-peptide receptor and stimulatory guanine-nucleotide-binding protein from rat liver.
Couvineau A; Rouyer-Fessard C; Voisin T; Laburthe M
Eur J Biochem; 1990 Feb; 187(3):605-9. PubMed ID: 2154377
[TBL] [Abstract][Full Text] [Related]
6. Effect of freezing on the coupling of VIP receptors to adenylate cyclase in rat liver membranes.
Robberecht P; Waelbroeck M; De Neef P; Camus JC; Gourlet P; Christophe J
Life Sci; 1988; 42(5):505-10. PubMed ID: 2828794
[TBL] [Abstract][Full Text] [Related]
7. Development of vasoactive intestinal peptide-responsive adenylate cyclase during enterocytic differentiation of Caco-2 cells in culture. Evidence for an increased receptor level.
Laburthe M; Rousset M; Rouyer-Fessard C; Couvineau A; Chantret I; Chevalier G; Zweibaum A
J Biol Chem; 1987 Jul; 262(21):10180-4. PubMed ID: 3038870
[TBL] [Abstract][Full Text] [Related]
8. G proteins in rat liver proliferation during cholestasis.
Rodriguez-Henche N; Guijarro LG; Couvineau A; Carrero I; Arilla E; Laburthe M; Prieto JC
Hepatology; 1994 Oct; 20(4 Pt 1):1041-7. PubMed ID: 7927206
[TBL] [Abstract][Full Text] [Related]
9. VIP receptor/effector system in liver membranes from cholestatic rats.
Rodriguez-Henche N; Guijarro LG; Bajo AM; Arilla E; Prieto JC
Peptides; 1994; 15(2):353-7. PubMed ID: 8008639
[TBL] [Abstract][Full Text] [Related]
10. G-protein regulation of adenylate cyclase activity in rat prostatic membranes after chronic ethanol ingestion.
Juarranz MG; Guijarro LG; Bodega G; Prieto JC
Prostate; 1998 Sep; 36(4):226-34. PubMed ID: 9719022
[TBL] [Abstract][Full Text] [Related]
11. Lindane decreases forskolin-stimulated cyclic AMP accumulation but does not modify Gs in rat enterocytes.
Carrero I; Rodríguez-Henche N; Guijarro LG; Recio MN; Pèrez-Albarsanz MA; Prieto JC
Cell Signal; 1993 Jul; 5(4):453-62. PubMed ID: 7690584
[TBL] [Abstract][Full Text] [Related]
12. The effect of streptozotocin diabetes on the vasoactive intestinal peptide receptor/effector system in membranes from rat ventral prostate.
Carmena MJ; Clemente C; Guijarro LG; Prieto JC
Endocrinology; 1992 Oct; 131(4):1993-8. PubMed ID: 1327726
[TBL] [Abstract][Full Text] [Related]
13. Solubilization of the liver vasoactive intestinal peptide receptor. Hydrodynamic characterization and evidence for an association with a functional GTP regulatory protein.
Couvineau A; Amiranoff B; Laburthe M
J Biol Chem; 1986 Nov; 261(31):14482-9. PubMed ID: 3021741
[TBL] [Abstract][Full Text] [Related]
14. Direct evidence for functional coupling of the vasoactive intestinal peptide receptor to Gi3 in native lung membranes.
Diehl NL; Kermode JC; Shreeve SM
Mol Pharmacol; 1996 Sep; 50(3):624-30. PubMed ID: 8794903
[TBL] [Abstract][Full Text] [Related]
15. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
[TBL] [Abstract][Full Text] [Related]
16. Interaction of thymic peptide thymosin alpha 1 with vasoactive intestinal peptide (VIP) receptors.
Calvo JR; Goberna R; Guerrero JM
Biosci Rep; 1986 Aug; 6(8):727-33. PubMed ID: 3028522
[TBL] [Abstract][Full Text] [Related]
17. Adenylate cyclase stimulation by VIP in rat and human parotid membranes.
van Bogaert P; Soukias Y; Dehaye JP; Lambert M; Poloczek P; Winand J; Mayer R; Christophe J
Regul Pept; 1987 Jun; 17(6):339-48. PubMed ID: 3602475
[TBL] [Abstract][Full Text] [Related]
18. Characterization and solubilization of vasoactive intestinal peptide receptors from rat lung membranes.
Provow S; Veliçelebi G
Endocrinology; 1987 Jun; 120(6):2442-52. PubMed ID: 3032591
[TBL] [Abstract][Full Text] [Related]
19. Characterization of vasoactive intestinal peptide receptors in human liver.
Rodríguez-Henche N; Rodríguez-Pena MS; Guijarro LG; Prieto JC
Biochim Biophys Acta; 1994 Mar; 1221(2):193-8. PubMed ID: 8148398
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
Gespach C; Bawab W; de Cremoux P; Calvo F
Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
